BALCX | HEIIX | BALCX / HEIIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 28 years | - |
Gain YTD | 9.431 | -0.594 | -1,586% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 236B | 57M | 414,035% |
Annual Yield % from dividends | 1.59 | 0.97 | 163% |
Returns for 1 year | 9.88 | -0.42 | -2,349% |
Returns for 3 years | 7.33 | -14.85 | -49% |
Returns for 5 years | 26.64 | -3.91 | -682% |
Returns for 10 years | 46.12 | -9.24 | -499% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FNFWX | 77.85 | 0.52 | +0.67% |
American Funds New World 529-F-2 | |||
RSECX | 16.27 | 0.09 | +0.56% |
Russell Inv US Strategic Equity C | |||
ETHSX | 12.91 | N/A | N/A |
Eaton Vance Worldwide Health Sci A | |||
SNPTX | 18.32 | N/A | N/A |
DWS Equity Sector Strategy Institutional | |||
HSLIX | 44.67 | -0.05 | -0.11% |
Hartford Small Cap Growth I |